PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|January 2, 2017
- Pharmaceutical Technology-01-02-2017
- Volume 41
- Issue 1
Fully Automated Capping Systems
The Thermo Scientific Decapper 500 and 550 series tube capping systems are fully automated capping systems for use in medium- to high-throughput biotech, pharmaceutical, and clinical laboratories doing compound storage, high-throughput screening, biobanking, and genomic storage.
The Thermo Scientific Decapper 500 and 550 series tube capping systems from Thermo Fisher Scientific and Hamilton Storage are fully automated capping systems for use in medium- to high-throughput biotech, pharmaceutical, and clinical laboratories doing compound storage, high-throughput screening, biobanking, and genomic storage. The systems allow users to cap and decap both Thermo Scientific Matrix and Nunc automation tubes without multiple pieces of equipment. The new decapper system features Quick Switch technology that allows users to transition between different tube and rack types. The systems can also cap and decap partial racks of tubes. The Decapper 550 provides additional functionality with its built-in barcode reader.
Articles in this issue
almost 10 years ago
Predicting Moisture Uptake in Solid Dosage Packagingalmost 10 years ago
Blister Packaging Moves Forwardalmost 10 years ago
Staffing and Preparation for Auditsalmost 10 years ago
Automatic Purge System for Control Panelsalmost 10 years ago
Spray Dryer for Efficient Microencapsulationalmost 10 years ago
Vials Reduce Risk of Drug Container Interactionsalmost 10 years ago
The Tide Stays Highalmost 10 years ago
Drug Quality Key to Innovation and Accessalmost 10 years ago
FDA New Drug Approvals Down Significantly in 2016almost 10 years ago
Beyond Distractions, Pharma Moves OnRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.